2 355

Cited 0 times in

Pharmacologic management of trigeminal nerve injury pain after dental implant surgery

Authors
 Ju Hyun Park  ;  Seok Hyoung Lee  ;  Seong Taek Kim 
Citation
 INTERNATIONAL JOURNAL OF PROSTHODONTICS, Vol.23(4) : 342-346, 2010 
Journal Title
 INTERNATIONAL JOURNAL OF PROSTHODONTICS 
ISSN
 0893-2174 
Issue Date
2010
MeSH
Adult ; Amines/therapeutic use ; Amitriptyline/therapeutic use ; Analgesics/therapeutic use ; Anticonvulsants/therapeutic use ; Antidepressive Agents/therapeutic use ; Antidepressive Agents, Second-Generation/therapeutic use ; Antidepressive Agents, Tricyclic/therapeutic use ; Cranial Nerve Injuries/drug therapy* ; Cyclohexanecarboxylic Acids/therapeutic use ; Cyclohexanols/therapeutic use ; Dental Implants*/adverse effects ; Female ; Follow-Up Studies ; Fructose/analogs & derivatives ; Fructose/therapeutic use ; Humans ; Male ; Middle Aged ; Nortriptyline/therapeutic use ; Pain Measurement ; Postoperative Complications/drug therapy* ; Prospective Studies ; Time Factors ; Trigeminal Nerve/drug effects ; Trigeminal Nerve Injuries* ; Trigeminal Neuralgia/drug therapy* ; Venlafaxine Hydrochloride ; Young Adult ; gamma-Aminobutyric Acid/therapeutic use
Abstract
PURPOSE: Injuries to the trigeminal nerve are a common postoperative complication of dental implant surgery. Usually, the altered sensation and neuropathic pain caused by the nerve injury is temporary, but a permanent neurosensory disorder can sometimes occur. Surgery is commonly used to treat this condition, but the treatment is associated with some complications and a relatively low success rate. This study analyzed the characteristics of pharmacologic management of trigeminal nerve injury pain after dental implant surgery. MATERIALS AND METHODS: Eighty-five patients who visited a temporomandibular joint and orofacial pain clinic with a history of trigeminal nerve injury pain after dental implant surgery were enrolled in this study. The pharmacologic management for trigeminal nerve injury pain was evaluated by prescribing a variety of medications for 12 weeks according to the prescription protocol of the study. The patients' pain characteristics, average percentage of pain reduction, and pain relieving factors were investigated prospectively. RESULTS: Patients who took anticonvulsants and antidepressants for at least 12 weeks reported a mean reduction in pain of 24.8%. Interestingly, patients who experienced an altered sensation and neuropathic pain for more than 1 year also reported a reduction in pain and discomfort, with an average decrease of 17.1%. In addition, it was found that early treatment using medications had a significant effect on reducing the level of pain and discomfort. CONCLUSION: These results suggest that pharmacologic management can be used for treating trigeminal nerve injury pain after dental implant surgery.
Full Text
http://www.quintpub.com/journals/ijp/abstract.php?iss2_id=674&article_id=8158&article=9&title=Pharmacologic Management of Trigeminal Nerve Injury Pain After Dental Implant Surgery
Appears in Collections:
2. College of Dentistry (치과대학) > Dept. of Orofacial Pain and Oral Medicine (구강내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Seong Taek(김성택)
Park, Ju Hyun(박주현)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/102177
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links